Interferon. induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells

被引:29
|
作者
Guan, Qingdong [1 ,2 ]
Ezzati, Peyman [3 ,4 ]
Spicer, Victor [3 ,4 ]
Krokhin, Oleg [3 ,4 ]
Wall, Donna [5 ]
Wilkins, John A. [3 ,4 ]
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Manitoba Ctr Adv Cell & Tissue Therapy, Winnipeg, MB, Canada
[2] CancerCare Manitoba, Cellular Therapy Lab, Winnipeg, MB, Canada
[3] Univ Manitoba, Rady Fac Hlth Sci, Dept Internal Med, Manitoba Ctr Prote & Syst Biol,Sect Biomed Prote, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[4] 799 John Buhler Res Ctr, Hlth Sci Ctr, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[5] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada
关键词
Proteomics; Human; 2D LC mass spectrometry; Interferon gamma; Mesenchymal stem/stromal cells ( MSC); Quantitative proteome profiling; Licensing; Membrane; STROMAL CELLS; STEM-CELLS; IFN-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; PROSTACYCLIN SYNTHASE; TGF-BETA; INDUCTION; IMMUNOSUPPRESSION; SUPPRESSION; ACTIVATION;
D O I
10.1186/s12014-017-9161-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Mesenchymal stem/stromal cells ( MSC) display a range of immunoregulatory properties which can be enhanced by the exposure to cytokines such interferon. ( IFN-gamma).However the compositional changes associated with the 'licensing' of these cells have not been clearly defined. The present study was undertaken to provide a detailed comparative proteomic analysis of the compositional changes that occur in human bone marrow derived MSC following 20 h treatment with IFN-gamma. Methods: 2D LC MSMS analysis of control and IFN-gamma treated cells from 5 different healthy donors provided confident identification of more than 8400 proteins. Results: In total 210 proteins were shown to be significantly altered in their expression levels (>=|2SD|) following IFN-gamma treatment. The changes for several of these proteins were confirmed by flow cytometry. STRING analysis determined that approximately 30% of the altered proteins physically interacted in described interferon mediated processes. Comparison of the list of proteins that were identified as changed in the proteomic analysis with data for the same proteins in the Interferome DB indicated that similar to 35% of these proteins have not been reported to be IFN-gamma responsive in a range of cell types. Conclusions: This data provides an in depth analysis of the proteome of basal and IFN-gamma treated human mesenchymal stem cells and it identifies a number of novel proteins that may contribute to the immunoregulatory capacity if IFN-gamma licensed cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Effect of High BMI on Human Bone Marrow-Derived Mesenchymal Stromal Cells
    Zong, Qiang
    Bundkirchen, Katrin
    Neunaber, Claudia
    Noack, Sandra
    CELL TRANSPLANTATION, 2024, 33
  • [32] Comparison of the osteogenic capacity of minipig and human bone marrow-derived mesenchymal stem cells
    Heino, Terhi J.
    Alm, Jessica J.
    Moritz, Niko
    Aro, Hannu T.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (07) : 1019 - 1025
  • [33] Bone Marrow Mesenchymal Stem Cells
    Ohishi, Masanobu
    Schipani, Ernestina
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 109 (02) : 277 - 282
  • [34] Human Fibroblasts Share Immunosuppressive Properties with Bone Marrow Mesenchymal Stem Cells
    Cappellesso-Fleury, Sandrine
    Puissant-Lubrano, Benedicte
    Apoil, Pol-Andre
    Titeux, Matthias
    Winterton, Peter
    Casteilla, Louis
    Bourin, Philippe
    Blancher, Antoine
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (04) : 607 - 619
  • [35] Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells
    Seib, F. Philipp
    Franke, Martina
    Jing, Duohui
    Werner, Carsten
    Bornhaeuser, Martin
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2009, 88 (05) : 257 - 271
  • [36] Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells
    Wang, Quanlei
    Wang, Yuwei
    Chang, Chongfei
    Ma, Feilong
    Peng, Dongxiu
    Yang, Shun
    An, Yanru
    Deng, Qiuting
    Wang, Qixiao
    Gao, Fei
    Wang, Fei
    Tang, Huiru
    Qi, Xufeng
    Jiang, Xiaoming
    Cai, Dongqing
    Zhou, Guangqian
    HELIYON, 2023, 9 (01)
  • [37] Human amnion-derived mesenchymal stem cells promote osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity
    Bian, Yifeng
    Ma, Xiaojie
    Wang, Ruixia
    Yuan, Hua
    Chen, Ning
    Du, Yifei
    FEBS OPEN BIO, 2019, 9 (01): : 74 - 81
  • [38] Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients
    Pedrosa, Monia
    Gomes, Joana
    Laranjeira, Paula
    Duarte, Catia
    Pedreiro, Susana
    Antunes, Brigida
    Ribeiro, Tania
    Santos, Francisco
    Martinho, Antonio
    Fardilha, Margarida
    Rosario Domingues, M.
    Abecasis, Manuel
    da Silva, Jose Antonio P.
    Paiva, Artur
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2020, 14 (01) : 16 - 28
  • [39] Isolation and Expansion of Mesenchymal Stem/Stromal Cells Derived from Human Placenta Tissue
    Pelekanos, Rebecca A.
    Sardesai, Varda S.
    Futrega, Kathryn
    Lott, William B.
    Kuhn, Michael
    Doran, Michael R.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (112):
  • [40] Immunomodulatory function of licensed human bone marrow mesenchymal stromal cell-derived apoptotic bodies
    Wang, Jiemin
    Donohoe, Ellen
    Canning, Aoife
    Moosavizadeh, Seyedmohammad
    Buckley, Fiona
    Brennan, Meadhbh A.
    Ryan, Aideen E.
    Ritter, Thomas
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125